Rationale and design of the efficacy of rivaroxaban on renal function in patients with non-valvular atrial fibrillation and chronic kidney disease: The X-NOAC study

Int J Cardiol. 2015 Jun 1:188:52-3. doi: 10.1016/j.ijcard.2015.04.037. Epub 2015 Apr 7.
No abstract available

Keywords: Atrial fibrillation; Chronic kidney disease; Non-Vitamin K antagonist oral anticoagulant; Oral factor Xa inhibitor; Warfarin.

Publication types

  • Letter
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Aged
  • Atrial Fibrillation / complications
  • Atrial Fibrillation / diagnosis*
  • Atrial Fibrillation / drug therapy*
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Female
  • Follow-Up Studies
  • Glomerular Filtration Rate / drug effects*
  • Heart Valves
  • Humans
  • Japan
  • Male
  • Middle Aged
  • Prospective Studies
  • Renal Insufficiency, Chronic / complications
  • Renal Insufficiency, Chronic / diagnosis
  • Renal Insufficiency, Chronic / drug therapy*
  • Risk Assessment
  • Rivaroxaban / administration & dosage*
  • Treatment Outcome
  • Warfarin / administration & dosage*

Substances

  • Warfarin
  • Rivaroxaban